Stealth BioTherapeutics (Convertible Debt)
Funding Details
- Awarder
- Inbox
- Date Award
- June 18, 2018
- Vertical
- Biotechnology
- Funding URL
- View Funding Page
- Funding Amount:
- $100,000,000
Company Info
- Company Description
- Stealth BioTherapeutics is a clinical-stage biotechnology company focused on genetic diseases.
- Market
- Mitochondrial diseases and neurodegenerative diseases
- Location
- Newton, MA, USA
- Coinvestors
- Atlantis Investment Management, BVCFCMBC Capital Holdings, Kingdon Capital, Morningside Venture, Ocean Equity Partners, Pivotal Beta, Sagamore Investments